baber/WOPTO huggingface dataset:
Patent MY-197401-A (MY)
Title: Connector, connecting and snap-locking structure for combined object-supporting carrier board, and combined object-supporting carrier board
Inventor: CHI JIE
IPC: B65D19/32
Filed: 2017-11-02
Abstract: The present invention discloses a connector (100), a connecting and snap-locking structure for a combined carrier board and a combined carrier board, the connector (100) includes a main body (1) one end of which is provided with an elastic rotary snap-fit portion (3) for snap-fitting into a carrier board through rotation, and the other end is provided with a twist lock portion (2) for snap-locking the carrier board and rotate the main body (1) through a cooperation with a twist lock tool. The present invention provides a simple structure, convenient manufacture, and low manufacture cost. The connector (100) and the snap-lock structure of the present invention cause an excellent assembly effect and high assembly efficiency, such that the assembled boards are secured. (Fig.11)
Patent MY-195860-A (MY)
Title: Use of Biomarkers in Identifying Cancer Patients That will be Responsive to Treatment with a Prmt5 Inhibitor
Inventor: BREHMER DIRK
IPC: C12Q1/48
Filed: 2018-02-26
Abstract: The present invention concerns a method of identifying a patient that is likely to be responsive to treatment with a protein arginine N-methyltransferase 5 (PRMT5) inhibitor comprising: evaluating a biological sample from the patient for the presence of a spliceosome alteration, wherein the presence of any said alteration indicates a higher likelihood for said patient to be responsive to treatment with said PRMT5 inhibitor than in the absence of any said mutation or alteration.
Patent MY-188420-A (MY)
Title: Crystalline forms of (s)-afoxolaner
Inventor: GORTER DE VRIES ROELOF JOHANNES
Filed: 2018-04-05
Abstract: The present invention provides crystalline forms of compound of formula (Ia) and processes of making the crystalline forms. Also provided are compositions comprising the crystalline forms and methods of use of the crystalline forms.
Patent SG-10201800954Q-A (SG)
Title: Method and system for signal processing rehabilitation exercise signals
Inventor: KOSAKA YUKI
Filed: 2018-02-02
Abstract: METHOD AND SYSTEM FOR SIGNAL PROCESSING REHABILITATION EXERCISE SIGNALS The present disclosure relates to method and system for signal processing rehabilitation exercise signals. The method comprises the step of receiving a first and a second motion signals associated with movements of a body part, wherein the motion signals comprise temporal data of the movements. The method further comprises the step of segmenting each of the first and second motion signals into a plurality of segmented signals based on gradients of the motion signals, wherein each segmented signal has consistent gradient. The method further comprises the step of automatically modifying the segmented signals to form multiple combinations of matching signals with similar gradients between the first and second motion signals, such that the first and second motion signals are in one-to-one correspondence. The method further comprises the step of extracting corresponding time intervals of the matching signals in the correspondences. Figure 1
Patent SG-10201803630X-A (SG)
Title: System and method for management of an additive manufacturing process
Inventor: William NG Hwee Tian
Filed: 2018-04-30
Abstract: SYSTEM AND METHOD FOR MANAGEMENT OF AN ADDITIVE MANUFACTURING PROCESS 5 A system for management of an additive manufacturing process including a user interface device arranged to perform at least one of the following actions in relation to a three dimensional product:- receive a request to print the three dimensional product; display at least one intermediate product associated with the three dimensional product; and receive a data file associated with the 10 three dimensional product; an encryption module configured to anonymize the request; and a database arranged in data communication with the user interface device to store any data file relating to the three dimensional product classified based on a plurality of categories. 15 (Figure 1)
Patent SG-10201805102P-A (SG)
Title: Audio coding method and related apparatus
Inventor: LIU ZEXIN
Filed: 2015-04-01
Abstract: An audio coding method and a related apparatus are disclosed. The audio coding method includes: performing time-frequency transformation processing on a time-domain signal of a current audio frame, to obtain spectral coefficients of the current audio frame; acquiring a reference coding parameter of the current audio frame; and if the acquired reference coding parameter of the 5 current audio frame satisfies a first parameter condition, coding the spectral coefficients of the current audio frame based on a transform coded excitation algorithm, or if the acquired reference coding parameter of the current audio frame satisfies a second parameter condition, coding the spectral coefficients of the current audio frame based on a high quality transform coding algorithm. The audio coding method and the related apparatus help improve coding quality or coding 10 efficiency of audio frame coding. [Figure 1]
Patent SG-10201806300V-A (SG)
Title: Liquid pharmaceutical composition
Inventor: RINALDI GIANLUCA
Filed: 2015-05-15
Abstract: LIQUID PHARMACEUTICAL COMPOSITION The present invention relates to novel liquid pharmaceutical compositions of adalimumab, which include adalimumab or a biosimilar thereof, an acetate buffering 5 agent/system such as sodium acetate/acetic acid, and a sugar stabiliser such as trehalose. Such a combination of components furnishes formulations having a stability (e.g. on storage and when exposed to stress) which is comparable to or an improvement upon those known in the art, and with fewer ingredients. Such advances will help adalimumab treatments to become more widely available at lower cost, and prolong the 10 viability of pre-loaded delivery devices (e.g. pre-filled syringes) to reduce unnecessary waste of the drug. (No Suitable Figure)
Patent SG-10201808292T-A (SG)
Title: Polycarbonate containing compositions
Inventor: LAKEMAN PASCAL E R E J
Filed: 2013-11-22
Abstract: POLYCARBONATE CONTAINING COMPOSITIONS Polycarbonate-containing compositions having desirable properties, such as good resistance to environmental stress cracking, are achieved using a combination of a polycarbonate polymer, a compatibilizing agent and an olefinic elastomer. The polycarbonate-containing composition may include about -98 weight percent of one or more carbonates polymers; about 0.1-10 weight percent of one or more compatibilizing agents; and 0.1-10 weight percent of one or more olefinic elastomers. The polycarbonate-containing compositions (e.g., polycarbonate blend compositions) preferably have good chemical resistance to medium chain triglycerides. The compositions may be employed in components, such as housings, that require resistance to cleaning fluids used in hospitals. For example, the composition may be employed in components that require resistance to hospital grade tuberculosis disinfectants. Figure for publication: None 31
Patent SG-10201809280P-A (SG)
Title: Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders
Inventor: MAEDA KENJI
Filed: 2015-04-22
Abstract: COMBINATION OF BREXPIPRAZOLE AND NALMEFENE AND USE THEREOF FOR TREATING SUBSTANCE-RELATED DISORDERS A medicament comprising (I) brexpiprazole or a pharmaceutically acceptable salt thereof, and (II) nalmefene or 5 a pharmaceutically acceptable salt thereof in combination, wherein brexpiprazole or a pharmaceutically acceptable salt thereof, and nalmefene or a pharmaceutically acceptable salt thereof are contained in a single preparation, or a pharmaceutical composition containing brexpiprazole or a 10 pharmaceutically acceptable salt thereof and a pharmaceutical composition containing nalmefene or a pharmaceutically acceptable salt thereof are formulated for use in combination. The medicament is used for the prophylaxis or treatment of a substance-related disorder, preferably an alcohol-related 15 disorder. (No drawing to be published)
Patent SG-10201810737T-A (SG)
Title: Lift pin assembly
Inventor: CHIA BONNIE T
Filed: 2015-05-28
Abstract: LIFT PIN ASSEMBLY Embodiments of lift pin assemblies are provided herein. In some embodiments, a lift pin assembly includes an elongate base formed of a first material and having a first feature formed in a distal end of the base to interface with and removably support a tip; and a tip formed of a second material different than the first material and having a support surface on a first side of the tip and an opposing second side of the tip, wherein the opposing second side includes a second feature to mate with the first feature of the base to removably retain the tip on the distal end of the base. [Figure ] 13
Patent SG-10201901398U-A (SG)
Title: Game Management System
Inventor: SHIGETA YASUSHI
Filed: 2019-02-19
Abstract: GAME MANAGEMENT SYSTEM A game management system for managing a casino game played on a gaming table of a casino facility includes: a camera which photographs a bet chip to obtain an image; a control device which specifies a bet amount for each player position on the gaming table on the basis of a position, a type, and the number of sheets of the chip in the image, a player number determination device which determines the number of players participating in a game on the gaming table, and a management control device which determines a recommended value of a minimum bet amount for each gaming table on the basis of information on a bet amount specified by the control device and information on the number of players determined by the player number determination device. Fig. 15
Patent SG-11201407618V-A (SG)
Title: Amorphous form of an akt inhibiting pyrimidinyl - cyclopentane compound, compositions and methods thereof
Inventor: CHAKRAVARTY PAROMA
IPC: C07D403/04
Filed: 2013-05-17
Abstract: (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau „ (10) International Publication Number (43) International Publication Date ^ ^ WO 2013/173811 A1 21 November 2013 (21.11.2013) WIPO I PCT (51) International Patent Classification: C07D 403/04 (2006.01) (21) International Application Number: (22) International Filing Date: (25) Filing Language: (26) Publication Language: PCT/US2013/041728 17 May 2013 (17.05.2013) English English (30) Priority Data: 61/648,536 17 May 2012 (17.05.2012) US (71) Applicant: GENENTECH, INC. [US/US]; 1 DNA Way, South San Francisco, California 94080-4990 (US). (72) Inventors: CHAKRAVARTY, Paroma; c/o Genentech, Inc., DNA 1 Way, South San Francisco, California 94080- 4990 (US). KOTHARI, Sanjeev; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080-4990 (US). GOSSELIN, Francis; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080-4990 (US). SAVAGE, Scott J.; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080-4990 (US). STULTS, Jeffrey; c/o Genentech, Inc., 1 DNA Way, South San Francisco, California 94080-4990 (US). (74) Agents: MALEN, Peter L. et al.; Viksnins Harris & Padys PLLP, 7900 International Drive, Suite 670, Bloomington, Minnesota 55425 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available)'. AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available)'. ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3)) 00 i> i-H o CJ (54) Title: AMORPHOUS FORM OF AN AKT INHIBITING PYRIMIDINYL TIONS AND METHODS THEREOF CYCLOPENTANE COMPOUND, COMPOSI- (57) Abstract: Disclosed is (5)-2-(4-chlorophenyl)-l-(4-((5i?,7i?)-7-hydroxy-5-methyl-6,7-dihydro-5i/-cyclopenta[fi?]pyrimidin-4- yl)piperazin-l-yl)-3-(isopropylamino)propan-l-one monohydrochloride, forms, formulations, pharmaceutical compositions, pro­ cesses of manufacturing and methods of use thereof.
Patent SG-11201804219W-A (SG)
Title: Pump unit and handheld high-pressure cleaning machine
Inventor: WU PINGHUA
IPC: F04C18/077
Filed: 2016-11-21
Abstract: The present invention relates to a pump unit applied to a high-pressure cleaning machine, including: a water inlet chamber, a water outlet chamber, and a central chamber connected to the water inlet chamber and the water outlet chamber. The pump unit further includes a plunger disposed in the central chamber and an eccentric mechanism connected 5 to the plunger. The eccentric mechanism drives the plunger to perform reciprocating motion in the central chamber.
Patent SG-11201901311W-A (SG)
Title: Triazolopyrazinone derivative useful as a human pde1 inhibitor
Inventor: REKHTER MARK DAVID
IPC: C07D471/14
Filed: 2017-08-18
Abstract: INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 01 March 2018 (01.03.2018) W I PO I PCT 0111111010 0111 °nolo O II oimIE (10) International Publication Number WO 2018/039051 Al (51) International Patent Classification: CO7D 471/14 (2006.01) A61P 13/12 (2006.01) A61K 31/4985 (2006.01) (21) International Application Number: PCT/US2017/047479 (22) International Filing Date: 18 August 2017 (18.08.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/379,372 25 August 2016 (25.08.2016) US (71) Applicant: ELI LILLY AND COMPANY [US/US]; Lilly Corporate Center, Indianapolis, Indiana 46285 (US). (72) Inventors: REKHTER, Mark David; c/o Eli Lilly and Company, P.O. Box 6288, Indianapolis, Indiana 46206-6288 (US). SHI, Qing; c/o Eli Lilly and Company, P.O. Box 6288, Indianapolis, Indiana 46206-6288 (US). (74) Agent: LENTZ, Nelsen L. et al.; Eli Lilly and Company, P.O. Box 6288, Indianapolis, Indiana 46206-6288 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: — with international search report (Art. 21(3)) 1-1 (54) Title: TRIAZOLOPYRAZINONE DERIVATIVE USEFUL AS A HUMAN PDE1 INHIBITOR O O 00 C N: (I) N (57) : The present invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use as a human PDE1 inhibitor.
Patent HU-184911-B (HU)
Inventor: BARAKKA IMRE
IPC: G01N27/02
Filed: 1980-01-09
Abstract: A találmány eljárás és berendezés timföldgyári zagyok és iszap szilárdanyag tartalmának és/vagy oldatfázis koncentrációjának folyamatos mérésére. Az eljárás szerint villamos vezetőképesség mérésével határozzák meg a közeg koncentrációját és egyidejűleg műanyag ablakkal ellátott mérőszakaszok lágy radio- aktív, előnyösen 24'Am sugárforrás által kibocsátott és az áramló közegen átvezetett sugárzás érzékelő-szervével meghatározzák a közeg szilárdanyag tartalmát és ez utóbbival villamos úton kompenzálják a vezetőképesség 5 jelét. A találmány egyben berendezés a találmány szerinti eljárás foganatosítására, amelynek mérőszakasza, abba beépített elektromos vezetőképességmérő érzékelője, valamint ahhoz csatlakoztatott kijelző szervvel ellátott villamos kiértékelő szerkezete van.  10 184911
Patent HU-199287-B (HU)
Title: Process for producing infusion solition containing glutaminic acid, asparaginic acid, glycerin and electrolites for treating liver metabolic disturbances and citotoxic cerebrel edema
Inventor: TULOK ISTVAN
IPC: A61K9/08
Filed: 1988-01-07
Abstract: Infusory soln. contg. aspartic acid, glycerol and electrolytes for treating liver metabolic disorders and cytotoxic brain-oedema is prepd. by adding 1 pt.wt. glutamic acid, 1 pt.wt. aspartic acid, 1.2-1.5 pts.wt. glycerol to a 68-75 g/l known semi-isotonic sodium-chloride soln. Other electrolytes, namely potassium-hydrogen-carbonate (pref. 0.2 pts.wt.) sodium-hydrogen-carbonate (0.8 pts.wt.) and 0.04 pts.wt. magnesium-oxide are also added.
Patent HU-191265-B (HU)
Title: Process for preparing 5-/2-alkoxy-phenyl/-thiazolidine-diones
Inventor: SCNUR RODNEY C
IPC: C07D277/34
Filed: 1984-01-16
Abstract: A series of 5-(2-alkoxyphenyl)thiazolidinediones and pharmaceutically acceptable salts thereof useful as hypoglycemic agents, aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications; intermediates therefore; and processes for preparation of said compounds.
Patent HU-189642-B (HU)
Inventor: SZILAGYI GYOERGY
IPC: E06C7/46
Filed: 1982-01-23
Abstract: A találmány biztonsági létratámasz, melynek rendeltetése, hogy laza, süppedős, homoktalajokon, főképpen gyümölcsösökben is lehetővé tegye a létra biztonságos használatát. Ennek megvalósításaként a létra lábaira (1) helytállóan felszerelhető támasztalpai (4) vannak, melyek a talajfelületre támaszkodva, a létra terhelése alatt is megakadályozzák annak a talajba sülyedését. A támasztalpak (4) rúddal (6, 12) vannak összekötve a létralábakkal (1) és konzolszerű kitámasztással biztosítják a talajra felfekvést és felületük nagyságával megakadályozzak a talajba süppedését. A támasztalpak (4, 9) el vannak látva a talajba mélyedhető csúszásgátlókkal (5a, 7b, 9b) is (1 és 2 ábrák). A támasztalpak készülhetnek vaslemezből is Í9), mely támasztrúdjával (6) és csúszásgátlóival (9b) a létralábakra (1) helytállóan vagy oldhatóan felszerelhető egységet képezve, házilag is felszerelhető (3 ábra). A támaszlap (4) és a létraláb (1) között csuklós kapcsolat (11) is alkalmazható, mely lehetővé teszi a támasztalpnak a létralábakhoz forgatását és a létralábak meghosszabbítását (4 ábra).  -1-
Patent HU-186842-B (HU)
Inventor: FEHER FERENC
IPC: C04B28/30
Filed: 1982-03-23
Abstract: A találmány tárgya eljárás fokozottan tűzálló, korrózióálló
és hőlökésálló olvasztott krómmullít tűzállóanyag
előállítására.
A találmány szerint olynódon járnak el, hogy
0,6 súly%-nál, előnyösen 0,3 súly%-nál kevesebb
Na2O-t tartalmazó timföldé, kvarchomokot, és
legfeljebb 5 mm szemcsenag/ságú nyers vagy dúsított
krómércet vagy krómoxidot 71—75 súlyrész
Al2O3-nak, 21-24 súlyrész SiO2-nek és 3-6 súlyrész
Cr2O3-nak megfelelő mennyiségben összekevernek,
homogenizálnak, a homogén olvadékot intenzív
hűtéssel,az első órában 280-200 °C/óra, a 2—
-5. órában 200-100 °C/óra sebességgel haladva lehűtik,
majd a lehűlt öntvényt kívánt esetben ismert
módon felaprítják és/vagy meg írlik.
Az így kapott termát előnyösen használható tűzálló
masszák és habarcsok, valamint tűzálló idomok
készítésére.
Patent HU-197677-B (HU)
Title: Apparatus particularly for discontinuous filtering suspensions and clarificated solutions
Inventor: ALFOELDI LASZLO
Filed: 1985-02-18
Abstract: The proposed method is intended for batch-wise filtration without loss, at a high rate, and to allow removal of the sepd. solid phase simply, in a dry form. Filtration is carried out in two interconnected spaces, maintained at the same pressure, in two immediately consecutive stages. - Appts. comprises a filter housing is fitted with an inner housing located on its geometric axis. The primary filter unit is located in the filter housing around a tubular shaft coaxial with the inner filter housing. The primary filter unit is pref. made up of filter bags and filter bed housings. It is movable along the axis of the filter housing. The filter bed housings are fixed on sealing rings located on filter elements. The secondary filter unit is located in the inner filter housing pref. in the form of a filter candle. Its inner space is connected, through valves to the inner space of the filter bags and the inner space of the filter housing.
Patent HU-184513-B (HU)
Title: Process for preparing prostaglandin-f down 2 alpha-derivatives
Inventor: STANEK JAN
IPC: C07D307/935
Filed: 1982-03-08
Abstract: A process for producing F2 alpha  prostaglandin and analogues thereof, in which a lactone diol or the C-15 epimer thereof is reacted with a 1-alkoxybenzyl halide in a solution of an aromatic hydrocarbon in the presence of a tertiary amine, at a temperature of - 20 to 40 DEG C and in a molar ratio of reacting components of 1.0: 1.0 to 1.1. The protected lactone is then reduced with a complex hydride at a temperature of - 80 to 20 DEG C. The lactol or C-15 epimer obtained by this reduction is then reacted with an "ylide" in a polar aprotic solvent to give the bisacetal of prostaglandin or the C-15 epimer thereof. The desired product is obtained using a 0.4 to 2 N oxalic acid solution or after isolation with a cation exchanger, in an aqueous medium with 10 to 80% by weight of an alcohol having 1 to 4 carbon atoms at a temperature of 20 to 80 DEG C. F2 alpha  prostaglandin and analogues thereof are biologically active and are used in human and veterinary medicine.
Patent HU-187060-B (HU)
Title: Method and device for hygienic taking and collecting edible and inedible animal blood
Inventor: BATORFALVI GEZA
IPC: A22B5/04
Filed: 1983-03-14
Abstract: A process for the hygienic extraction and separate collection of animal blood fit and unfit for consumption, comprises stunning the animals prior to stabbing and providing the animals with serial numbers suitable for identification of the carcass and the blood to be extracted. The spot of stabbing on the throat of the animals is disinfected and the animals are cyclically stepped into a stabbing position. The animal is stabbed in the stabbing position with a disinfected stabbing tool which is exchanged for each animal and is provided with a closed outlet a hose-fitted hollow knife. The hygenic blood is extracted through the stabbing tool into one of a plurality of rotating blood collecting tanks arranged on a turntable and moved into an extracting position. An anticoagulant is added to the blood by gravity feed and after filling, the tanks are advanced toward into a first draining position for blood fit for consumption. If all the numbered carcasses pertinent to the blood in the tank in the first drawing position are held impeccable from the point of view of animal healthy examination, a control body effects the draining the blood from the collecting tank into a system for blood fit for consumption. If not impeccable, the tank is advanced with the blood in it forward to a second draining position and drained into a system for blood unfit for consumption. The drained tanks are washed and disinfected and advanced into the extracting position.